Skip to main content

MoneyWorks4Me

Kwality Pharmaceuticals informs about status of investors complaints

20 Jan 2018 Evaluate

Kwality Pharmaceuticals has informed that in Compliance with Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), the status of Investors Complaints for the quarter ended on 31st December, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1765.55
Dr. Reddys Labs. 1357.60
Cipla 1375.80
Lupin 2021.60
Zydus Lifesciences 1236.40
View more..